Advertisement

Topics

Proteostasis Therapeutics files IND for PTI-808, cystic fibrosis potentiator

12:00 EDT 3 Jul 2017 | CentreWatch

Proteostasis Therapeutics, a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing such as cystic fibrosis (CF), announced that the company has filed an Investigational New Drug (IND) application with the FDA for PTI-808, its cystic fibrosis transmembrane conductance regulator (CFTR) potentiator. Proteostasis plans to initiate a phase I study […]

The post Proteostasis Therapeutics files IND for PTI-808, cystic fibrosis potentiator appeared first on CenterWatch News Online.

Original Article: Proteostasis Therapeutics files IND for PTI-808, cystic fibrosis potentiator

NEXT ARTICLE

More From BioPortfolio on "Proteostasis Therapeutics files IND for PTI-808, cystic fibrosis potentiator"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...